Challenges of designing an AI platform for Drug Discovery w/ Marek Kultys
Our Senior Product Designer explores the design process at BenevolentAI where he builds user facing tools that help our scientists discover and develop new medicines.
Charting the progress of BenevolentAI’s collaboration with AstraZeneca
AstraZeneca and Benevolent share their experiences of working together on CKD and IPF using both teams expertise in data and machine learning.
Introducing our latest research at NeurIPS2019
Machine learning and artificial intelligence represent an incredible opportunity for the health sector. Our team of AI and biomedical scientists present their latest research at NeurIPS 2019
Research: Biomedical relation extraction (BERT)
In a recent paper, we proposed a new relation extraction model built on top of BERT. Given any paragraph of text, our model will extract all gene-disease pairs which exhibit a pre-specified relation.
WHAT we do
Why it matters
What we do
Company Registration: 09781806
Terms & Conditions
Privacy & Cookies Policy